Impact of increasing number of mental health conditions on healthcare costs and resource utilization among individuals with type 2 diabetes: a cross-sectional study

IF 0.5 Q4 HEALTH CARE SCIENCES & SERVICES Journal of Pharmaceutical Health Services Research Pub Date : 2024-04-03 DOI:10.1093/jphsr/rmae008
M. Bounthavong, Aysell Medina, Brooke M Wallace, Aryana Sepassi, C. Morello
{"title":"Impact of increasing number of mental health conditions on healthcare costs and resource utilization among individuals with type 2 diabetes: a cross-sectional study","authors":"M. Bounthavong, Aysell Medina, Brooke M Wallace, Aryana Sepassi, C. Morello","doi":"10.1093/jphsr/rmae008","DOIUrl":null,"url":null,"abstract":"\n \n \n To evaluate the association between the number of mental health conditions among individuals with type 2 diabetes (T2D) and healthcare expenditures in the USA.\n \n \n \n A cross-sectional study was conducted to evaluate the relationship between multiple mental health conditions (0, 1, and 2 or more mental health conditions) among individuals with T2D on healthcare expenditures using data from the 2019 US Medical Expenditure Panel Survey.\n \n \n \n A total of 24,091,931 weighted individuals with T2D were included for analysis; 76.8% had no co-occurring mental health conditions, 15.5% had one mental health condition, and 7.7% had two or more mental health conditions. Individuals with one and two or more mental health conditions had significantly greater total healthcare costs (+$7135 and +$7168), office-based costs (+$1196 and +$1483), prescription costs (+$2091 and +$3757), office-based visits (+3.55 and +6.46), and prescriptions fills (+13.97 and +26.77) than individuals with no mental health conditions.\n \n \n \n Individuals with T2D and an increasing number of co-occurring mental health conditions were associated with increased healthcare costs and resource utilization. Underlying mechanisms for this relationship remain unclear, and further investigations are needed to accurately assess the impact this may have on health outcomes.\n","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Health Services Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jphsr/rmae008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

To evaluate the association between the number of mental health conditions among individuals with type 2 diabetes (T2D) and healthcare expenditures in the USA. A cross-sectional study was conducted to evaluate the relationship between multiple mental health conditions (0, 1, and 2 or more mental health conditions) among individuals with T2D on healthcare expenditures using data from the 2019 US Medical Expenditure Panel Survey. A total of 24,091,931 weighted individuals with T2D were included for analysis; 76.8% had no co-occurring mental health conditions, 15.5% had one mental health condition, and 7.7% had two or more mental health conditions. Individuals with one and two or more mental health conditions had significantly greater total healthcare costs (+$7135 and +$7168), office-based costs (+$1196 and +$1483), prescription costs (+$2091 and +$3757), office-based visits (+3.55 and +6.46), and prescriptions fills (+13.97 and +26.77) than individuals with no mental health conditions. Individuals with T2D and an increasing number of co-occurring mental health conditions were associated with increased healthcare costs and resource utilization. Underlying mechanisms for this relationship remain unclear, and further investigations are needed to accurately assess the impact this may have on health outcomes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
精神疾病数量增加对 2 型糖尿病患者医疗成本和资源利用率的影响:一项横断面研究
目的:评估美国 2 型糖尿病(T2D)患者的精神健康状况数量与医疗支出之间的关系。 我们利用 2019 年美国医疗支出小组调查的数据开展了一项横断面研究,以评估 2 型糖尿病患者的多种精神健康状况(0、1 和 2 种或更多精神健康状况)与医疗支出之间的关系。 共纳入 24,091,931 名加权 T2D 患者进行分析;76.8% 的患者没有并发精神疾病,15.5% 的患者有一种精神疾病,7.7% 的患者有两种或两种以上精神疾病。与没有精神疾病的人相比,有一种和两种或两种以上精神疾病的人的总医疗费用(+7135 美元和+7168 美元)、门诊费用(+1196 美元和+1483 美元)、处方费用(+2091 美元和+3757 美元)、门诊次数(+3.55 次和+6.46 次)和处方开具次数(+13.97 次和+26.77 次)均显著增加。 患有 T2D 且同时患有多种精神疾病的患者,其医疗成本和资源利用率都会增加。这种关系的内在机制尚不清楚,需要进一步的调查来准确评估其对健康结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Pharmaceutical Health Services Research
Journal of Pharmaceutical Health Services Research HEALTH CARE SCIENCES & SERVICES-
CiteScore
1.50
自引率
0.00%
发文量
45
期刊最新文献
The revised patient attitudes to deprescribing (rPATD) questionnaire: an investigation using a large anonymized database Evaluation of a structured pharmacist-led intervention on glycemic control in underprivileged diabetic patients: a randomized open-label trial Cross-sectional study of pharmacists’ knowledge and beliefs about human papillomavirus, its vaccines, and barriers related to vaccine administration Analysis of cancer drugs receiving FDA’s Accelerated Approval between 1992 and 2021 Navigating digital health: perspectives of Australian community pharmacists—a short communication
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1